Gyre Therapeutics announced the resignation of Ying Luo, Ph.D., from his roles as Chairman and board member to focus on other responsibilities at GNI Group Ltd. The company appointed Ping Zhang as ...

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing ...